CL
Not exactly a panic sell
Sumitomo Mitsui Trust Group Inc. trimmed its Colgate-Palmolive stake by 81,070 shares, taking the position down 4.1% to 1,878,388 shares. That still works out to roughly 0.23% of the company, or about $148.4 million at quarter-end. So no, this isn’t the kind of exit that sends you sprinting for the exits — more like shaving a little off the top.
Why investors should care
When a big holder dials back exposure, the market likes to play detective: was this a portfolio tweak, a risk-off move, or just someone rebalancing after a good run? On its own, the sale isn’t a crisis. But it’s still a datapoint on who’s willing to hold Colgate at current prices.
The dividend keeps doing dividend things
Colgate also boosted its quarterly dividend to $0.53 a share, or $2.12 annualized, with an ex-dividend date of April 20 and a payment date of May 15. Translation: the stock is still doing what boring-but-beautiful consumer staples stocks are supposed to do — quietly hand out cash while the world argues about everything else.
Analysts are still mostly waving it through
The analyst tape isn’t screaming either. Wells Fargo cut its price target to $92 and kept an equal-weight stance, Deutsche Bank moved the stock up from hold to buy, and the broader consensus still sits around Moderate Buy. In other words, CL remains the kind of name investors tuck into the defensive drawer when the market starts acting like a caffeinated squirrel.
Big picture: A modest stake trim doesn’t change Colgate’s story much. Between the dividend lift and steady analyst support, this still looks like a classic defensive hold — not thrilling, but often exactly the point.